Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225.

Busam KJ, Capodieci P, Motzer R, Kiehn T, Phelan D, Halpern AC.

Br J Dermatol. 2001 Jun;144(6):1169-76.

PMID:
11422037
[PubMed - indexed for MEDLINE]
2.

Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.

Prewett M, Rothman M, Waksal H, Feldman M, Bander NH, Hicklin DJ.

Clin Cancer Res. 1998 Dec;4(12):2957-66.

PMID:
9865906
[PubMed - indexed for MEDLINE]
Free Article
3.
4.

[Skin signs associated with epidermal growth factor inhibitors].

Hannoud S, Rixe O, Bloch J, Le Pelletier F, Lebrun-Vignes B, Doarika A, Khayat D, Chosidow O.

Ann Dermatol Venereol. 2006 Mar;133(3):239-42. French.

PMID:
16800173
[PubMed - indexed for MEDLINE]
5.

Augmentation of a humanized anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225.

Ye D, Mendelsohn J, Fan Z.

Oncogene. 1999 Jan 21;18(3):731-8.

PMID:
9989823
[PubMed - indexed for MEDLINE]
Free Article
6.

Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy.

Ciardiello F, Bianco R, Caputo R, Caputo R, Damiano V, Troiani T, Melisi D, De Vita F, De Placido S, Bianco AR, Tortora G.

Clin Cancer Res. 2004 Jan 15;10(2):784-93.

PMID:
14760102
[PubMed - indexed for MEDLINE]
Free Article
7.

Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor.

Gencoglan G, Ceylan C.

Skin Pharmacol Physiol. 2007;20(5):260-2. Epub 2007 Jul 19.

PMID:
17641540
[PubMed - indexed for MEDLINE]
8.

Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice.

Karashima T, Sweeney P, Slaton JW, Kim SJ, Kedar D, Izawa JI, Fan Z, Pettaway C, Hicklin DJ, Shuin T, Dinney CP.

Clin Cancer Res. 2002 May;8(5):1253-64.

PMID:
12006546
[PubMed - indexed for MEDLINE]
Free Article
9.

Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.

Ciardiello F, Caputo R, Bianco R, Damiano V, Pomatico G, Pepe S, Bianco AR, Agrawal S, Mendelsohn J, Tortora G.

J Natl Cancer Inst. 1998 Jul 15;90(14):1087-94.

PMID:
9672257
[PubMed - indexed for MEDLINE]
Free Article
10.

Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.

Baselga J, Pfister D, Cooper MR, Cohen R, Burtness B, Bos M, D'Andrea G, Seidman A, Norton L, Gunnett K, Falcey J, Anderson V, Waksal H, Mendelsohn J.

J Clin Oncol. 2000 Feb;18(4):904-14.

PMID:
10673534
[PubMed - indexed for MEDLINE]
12.

Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A.

Ciardiello F, Damiano V, Bianco R, Bianco C, Fontanini G, De Laurentiis M, De Placido S, Mendelsohn J, Bianco AR, Tortora G.

J Natl Cancer Inst. 1996 Dec 4;88(23):1770-6.

PMID:
8944008
[PubMed - indexed for MEDLINE]
Free Article
13.

Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer.

Shin DM, Donato NJ, Perez-Soler R, Shin HJ, Wu JY, Zhang P, Lawhorn K, Khuri FR, Glisson BS, Myers J, Clayman G, Pfister D, Falcey J, Waksal H, Mendelsohn J, Hong WK.

Clin Cancer Res. 2001 May;7(5):1204-13.

PMID:
11350885
[PubMed - indexed for MEDLINE]
Free Article
14.

Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.

Ciardiello F, Bianco R, Damiano V, De Lorenzo S, Pepe S, De Placido S, Fan Z, Mendelsohn J, Bianco AR, Tortora G.

Clin Cancer Res. 1999 Apr;5(4):909-16.

PMID:
10213228
[PubMed - indexed for MEDLINE]
Free Article
15.

[Cutaneous side effects of EGF receptor inhibitors].

Nassar D, Soutou B, Aractingi S.

Bull Cancer. 2009 Dec;96 Suppl:S85-91. doi: 10.1684/bdc.2009.1000. French.

PMID:
20034874
[PubMed - indexed for MEDLINE]
16.

The epidermal growth factor receptor pathway and its inhibition as anticancer therapy.

Janmaat ML, Giaccone G.

Drugs Today (Barc). 2003;39 Suppl C:61-80. Review.

PMID:
14988746
[PubMed - indexed for MEDLINE]
17.

Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD1839), an inhibitor of epidermal growth factor.

Lee MW, Seo CW, Kim SW, Yang HJ, Lee HW, Choi JH, Moon KC, Koh JK.

Acta Derm Venereol. 2004;84(1):23-6.

PMID:
15040473
[PubMed - indexed for MEDLINE]
18.

Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor.

Van Doorn R, Kirtschig G, Scheffer E, Stoof TJ, Giaccone G.

Br J Dermatol. 2002 Sep;147(3):598-601.

PMID:
12207609
[PubMed - indexed for MEDLINE]
19.

Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor.

Vanhoefer U, Tewes M, Rojo F, Dirsch O, Schleucher N, Rosen O, Tillner J, Kovar A, Braun AH, Trarbach T, Seeber S, Harstrick A, Baselga J.

J Clin Oncol. 2004 Jan 1;22(1):175-84.

PMID:
14701780
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk